Search Results - "Labroli MA"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Discovery of potent wall teichoic acid early stage inhibitors.

    Authors: Labroli MA Caldwell JP Yang C et al.

    Source: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2016 Aug 15; Vol. 26 (16), pp. 3999-4002. Date of Electronic Publication: 2016 Jun 30.

    Publication Type: Journal Article

    Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE

    Save to List
  2. 2

    The identification of novel 5'-amino gemcitabine analogs as potent RRM1 inhibitors.

    Authors: Labroli MA Dwyer MP Shen R et al.

    Source: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2014 Apr 01; Vol. 22 (7), pp. 2303-10. Date of Electronic Publication: 2014 Feb 15.

    Publication Type: Journal Article

    Journal Info: Publisher: Elsevier Science Country of Publication: England NLM ID: 9413298 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3391 (Electronic) Linking ISSN: 09680896 NLM ISO Abbreviation: Bioorg Med Chem Subsets: MEDLINE

    Save to List
  3. 3

    Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist.

    Authors: Tagat JR McCombie SW Nazareno D et al.

    Source: Journal of medicinal chemistry [J Med Chem] 2004 May 06; Vol. 47 (10), pp. 2405-8.

    Publication Type: Journal Article

    Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print Cited Medium: Print ISSN: 0022-2623 (Print) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

    Save to List
  4. 4

    10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathway.

    Authors: Marsilje TH Labroli MA Hedrick MP et al.

    Source: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2002 Aug; Vol. 10 (8), pp. 2739-49.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

    Journal Info: Publisher: Elsevier Science Country of Publication: England NLM ID: 9413298 Publication Model: Print Cited Medium: Print ISSN: 0968-0896 (Print) Linking ISSN: 09680896 NLM ISO Abbreviation: Bioorg Med Chem Subsets: MEDLINE

    Save to List
  5. 5

    The synthesis of amino-acid functionalized beta-carbolines as topoisomerase II inhibitors.

    Authors: Deveau AM Labroli MA Dieckhaus CM et al.

    Source: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2001 May 21; Vol. 11 (10), pp. 1251-5.

    Publication Type: Journal Article

    Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print Cited Medium: Print ISSN: 0960-894X (Print) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE

    Save to List
  6. 6

    Conformationally restricted analogues designed for selective inhibition of GAR Tfase versus thymidylate synthase or dihydrofolate reductase.

    Authors: Boger DL Labroli MA Marsilje TH et al.

    Source: Bioorganic & medicinal chemistry [Bioorg Med Chem] 2000 May; Vol. 8 (5), pp. 1075-86.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

    Journal Info: Publisher: Elsevier Science Country of Publication: England NLM ID: 9413298 Publication Model: Print Cited Medium: Print ISSN: 0968-0896 (Print) Linking ISSN: 09680896 NLM ISO Abbreviation: Bioorg Med Chem Subsets: MEDLINE

    Save to List
  7. 7

    The synthesis and evaluation of benzannelated-azatoxins: the benzazatoxins.

    Authors: Miller TA Vachaspati PR Labroli MA et al.

    Source: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 1998 May 05; Vol. 8 (9), pp. 1065-70.

    Publication Type: Journal Article

    Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print Cited Medium: Print ISSN: 0960-894X (Print) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE

    Save to List

Search Tools: